186 related articles for article (PubMed ID: 20549136)
1. Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.
Pereira BJ; Castro I; Burdmann EA; Malheiros DM; Yu L
Braz J Med Biol Res; 2010 Aug; 43(8):737-44. PubMed ID: 20549136
[TBL] [Abstract][Full Text] [Related]
2. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
3. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
4. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
5. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
Russ G; Segoloni G; Oberbauer R; Legendre C; Mota A; Eris J; Grinyó JM; Friend P; Lawen J; Hartmann A; Schena FP; Lelong M; Burke JT; Neylan JF;
Transplantation; 2005 Nov; 80(9):1204-11. PubMed ID: 16314787
[TBL] [Abstract][Full Text] [Related]
6. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury.
Inman SR; Davis NA; Olson KM; Lukaszek VA; McKinley MR; Seminerio JL
Urology; 2003 Oct; 62(4):750-4. PubMed ID: 14550466
[TBL] [Abstract][Full Text] [Related]
8. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.
Lieberthal W; Fuhro R; Andry CC; Rennke H; Abernathy VE; Koh JS; Valeri R; Levine JS
Am J Physiol Renal Physiol; 2001 Oct; 281(4):F693-706. PubMed ID: 11553517
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
[TBL] [Abstract][Full Text] [Related]
11. Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.
Kamar N; Allard J; Ribes D; Durand D; Ader JL; Rostaing L
Clin Nephrol; 2005 Feb; 63(2):80-6. PubMed ID: 15730049
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
13. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat.
Sereno J; Vala H; Nunes S; Rocha-Pereira P; Carvalho E; Alves R; Teixeira F; Reis F
J Physiol Pharmacol; 2015 Apr; 66(2):285-99. PubMed ID: 25903959
[TBL] [Abstract][Full Text] [Related]
15. Protective Role of Apelin Against Cyclosporine-Induced Renal Tubular Injury in Rats.
Kim JS; Yang JW; Han BG; Kwon HJ; Kim JH; Choi SO
Transplant Proc; 2017; 49(6):1499-1509. PubMed ID: 28736029
[TBL] [Abstract][Full Text] [Related]
16. Can we eliminate both calcineurin inhibitors and steroids?
Lebranchu Y
Transplant Proc; 2010 Nov; 42(9 Suppl):S25-8. PubMed ID: 21095446
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine or FK506 decrease mature epidermal growth factor protein expression and renal tubular regeneration in rat kidneys with ischemia/reperfusion injury.
Yang CW; Lee SH; Lim SW; Jung JY; Kim WY; Kim HW; Choi BS; Li C; Cha JH; Kim YS; Kim J; Bang BK
Nephron; 2002 Dec; 92(4):914-21. PubMed ID: 12399639
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulphide as a novel therapy to ameliorate cyclosporine nephrotoxicity.
Lee G; Hosgood SA; Patel MS; Nicholson ML
J Surg Res; 2015 Aug; 197(2):419-26. PubMed ID: 25990693
[TBL] [Abstract][Full Text] [Related]
19. Beneficial and harmful effects of L-arginine on renal ischaemia.
Tomé LA; Yu L; de Castro I; Campos SB; Seguro AC
Nephrol Dial Transplant; 1999 May; 14(5):1139-45. PubMed ID: 10344352
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.
Ventura CG; Coimbra TM; de Campos SB; de Castro I; Yu L; Seguro AC
J Am Soc Nephrol; 2002 Oct; 13(10):2524-33. PubMed ID: 12239241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
